robert pearmarch washington massachusetts led nation expanding health insurance coverage wants rein growth prescription drug spending low income people medicaid proposals met icy reaction patients drug companies state asked trump administration permission limit number drugs covered medicaid program seeking exclude drugs limited inadequate evidence clinical efficacy proposal nationwide implications many states struggling costs health care including prescription drugs massachusetts officials say decision request medicaid waiver could set national precedent approved show serious president trump vow bring drug prices consumer advocates drug companies mobilized campaign block proposal telling administration would deprive medicaid beneficiaries access innovative lifesaving treatments moreover say would radical departure grand bargain struck years ago medicaid covers nearly company prescription drugs company agrees provide deep discounts medicaid massachusetts officials said proud coverage gains made since state adopted health law served many ways model affordable care act signed four years later president barack obama drug spending massachusetts health program doubled last five years billion threatens crowd important spending health care critical programs state said asking trump administration medicaid waiver massachusetts medicaid children health insurance program combined one program called masshealth accounts percent state budget marylou sudders state secretary health human services pointed one reason growing costs steady increase number residents enrolled masshealth covers nearly percent state residents simultaneous decline proportion people covered commercial insurance manage rising drug spending massachusetts gov charlie baker moderate republican says wants use tools widely employed commercial insurers state officials want establish list covered drugs describe proposal commercial style closed formulary least one drug available per therapeutic class ability exclude drugs state said able negotiate better deals drug manufacturers guaranteeing additional sales drugs cover return larger discounts rebates state officials want able exert market leverage believe large purchaser prescription drugs without constrained see arcane obsolete federal rules said tom dehner former medicaid director massachusetts massachusetts said also wanted use rigorous review process identify new drugs whose clinical benefits proved way said state could avoid exorbitant spending high cost drugs medically necessary mr trump budget coming year includes legislative proposal medicaid demonstration project would allow five states determine drug formularies much massachusetts wants medicaid officials arizona said would like discretion decide drugs covered please verify youre robot clicking box invalid email address please enter must select newsletter subscribe view new york times newsletters among criticized massachusetts proposal health care consumer advocacy group boston american medical association american academy pediatrics american cancer society cancer action network american diabetes association national alliance mental illness drugmakers including amgen johnson johnson eli lilly merck pfizer teva proposed waiver reverse massachusetts standing leader public health harm low income patients depend medicaid said harold p wimmer chief executive american lung association possibility making available one drug therapeutic class real threat patients lung cancer asthma often need one medication said letter federal health officials nonprofit groups help people diabetes epilepsy cystic fibrosis echoed concern sharon torgerson spokeswoman health human services office massachusetts said ms sudders head agency daniel tsai state medicaid director would comment criticism state discussing proposal federal government objections drugmakers remarkably similar concerns expressed patient advocacy groups massachusetts proposal would dramatically limit access lifesaving therapies poorest vulnerable patients wayne sichel pharmacist lawyer bristol myers squibb said comments sent trump administration dr joshua j ofman senior vice president amgen said proposed medicaid waiver would tear apart basic bargain enacted congress proposal said massachusetts would renege obligations would expect drug manufacturers continue providing price concessions required law said fundamentally unfair massachusetts officials said targeting certain costly new drugs received accelerated approval food drug administration using procedure agency example approve medication shrinks tumors without waiting clinical trials show whether patients actually live longer patients advocates said drugs sometimes best option people life threatening diseases andy schmeltz senior vice president pfizer said federal approval massachusetts waiver would undercut f role substituting judgment state officials experts federal agency massachusetts said would exceptions process consumers could use request coverage drugs formulary might medically necessary individual cases version article appears print april page new york edition headline massachusetts tackling drug cost fight order reprints todays paper subscribe interested feedback page tell us think go home page